Effects of Schisandra Lignans on P-Glycoprotein-Mediated Drug Efflux in Human Intestinal Caco-2 Cells

Development of inhibitors of ATP-binding cassette drug transporters – present status and challenges

Shukla, S., Wu, C., & Ambudkar, S. V. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.2.205 · Cited by 253 · see citing works

Analysis of Schisandra chinensis and Schisandra sphenanthera

Lu, Y., & Chen, D.-F. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2008.09.070 · Cited by 249 · see citing works

A comprehensive review of ethnopharmacology, phytochemistry, pharmacology, and pharmacokinetics of Schisandra chinensis (Turcz.) Baill. and Schisandra sphenanthera Rehd. et Wils.

Yang, K., Qiu, J. Y., Huang, Z., Yu, Z., Wang, W., Hu, H., & You, Y. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114759 · Cited by 186 · see citing works

Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy

Wu, C., Ohnuma, S., & Ambudkar, S. V. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111795163887 · Cited by 172 · see citing works

Pharmacokinetic herb-drug interactions (part 2): Drug interactions involving popular botanical dietary supplements and their clinical relevance

Gurley, B., Fifer, E., & Gardner, Z. (2012) · Planta Medica · doi:10.1055/s-0031-1298331 · Cited by 165 · see citing works

Updates on the Clinical Evidenced Herb‐Warfarin Interactions

Ge, B., Zhang, Z., & Zuo, Z. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/957362 · Cited by 140 · see citing works

Plant Adaptogens—History and Future Perspectives

Todorova, V., Ivanov, K., Delattre, C., Nalbantova, V., Karcheva-Bahchevanska, D., & Ivanova, S. (2021) · Nutrients · doi:10.3390/nu13082861 · Cited by 121 · see citing works

Anti-inflammatory properties of anthraquinones and their relationship with the regulation of P-glycoprotein function and expression

Choi, R. J., Ngoc, T. M., Bae, K., Cho, H., Kim, D., Chun, J., Khan, S., & Kim, Y. S. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.10.027 · Cited by 96 · see citing works

Mechanistic understanding of the different effects of Wuzhi Tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK506)

Qin, X. L., Bi, H. C., Wang, X. D., et al. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.025 · Cited by 90 · see citing works

Targeting multidrug resistance in cancer by natural chemosensitizers

Hamed, A. R., Abdel‐Azim, N. S., Shams, K. A., & Hammouda, F. M. (2019) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-019-0043-8 · Cited by 84 · see citing works

Phytochemicals: Potential Lead Molecules for MDR Reversal

Tinoush, B., Shirdel, I., & Wink, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00832 · Cited by 83 · see citing works

Reversing Agents for ATP-Binding Cassette Drug Transporters

Lee, C. H. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_14 · Cited by 80 · see citing works

Phytochemicals reverse P-glycoprotein mediated multidrug resistance via signal transduction pathways

Muthusamy, G., Kanimozhi, G., Bharathiraja, P., Khan, H. A., Alhomida, A. S., Ekhzaimy, A. A., Brindha, G., & Prasad, N. R. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111632 · Cited by 82 · see citing works

Pharmacokinetic herb–drug interactions with traditional Chinese medicine: progress, causes of conflicting results and suggestions for future research

Ma, B., & Ma, Y. (2016) · Drug Metabolism Reviews · doi:10.3109/03602532.2015.1124888 · Cited by 68 · see citing works

Effect of Tacrolimus on the pharmacokinetics of bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) and the potential roles of CYP3A and P-gp

Qin, X., Chen, X., Zhong, G.-P., et al. (2014) · Phytomedicine · doi:10.1016/j.phymed.2013.12.006 · Cited by 60 · see citing works

In Vivo to In Vitro Effects of Six Bioactive Lignans of Wuzhi Tablet (Schisandra Sphenanthera Extract) on the CYP3A/P-glycoprotein–Mediated Absorption and Metabolism of Tacrolimus

Qin, X. L., Chen, X., Wang, Y., et al. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.053892 · Cited by 60 · see citing works

Herb-drug Interactions Involving Drug Metabolizing Enzymes and Transporters

Liu, C., Yi, X., Si, D., Xiao, X., He, X., & Li, Y.-Z. (2011) · Current Drug Metabolism · doi:10.2174/138920011797470083 · Cited by 55 · see citing works

Pharmacokinetic Compatibility of Ginsenosides and Schisandra Lignans in Shengmai-san: From the Perspective of P-Glycoprotein

Liang, Y., Zhou, Y., Zhang, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098717 · Cited by 40 · see citing works

Effect of long-term co-administration of Wuzhi tablet (Schisandra sphenanthera extract) and prednisone on the pharmacokinetics of tacrolimus

Qin, X., Yu, T., Li, L.-J., et al. (2012) · Phytomedicine · doi:10.1016/j.phymed.2012.11.008 · Cited by 39 · see citing works

A comprehensive review of Schisandra chinensis lignans: pharmacokinetics, pharmacological mechanisms, and future prospects in disease prevention and treatment

Ehambarampillai, D., & Wan, M. L. Y. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01096-z · Cited by 49 · see citing works

Effect of Wuzhi Tablet (Schisandra sphenanthera extract) on the Pharmacokinetics of Cyclosporin A in Rats

Xue, X., Qin, X., Xu, C., et al. (2012) · Phytotherapy Research · doi:10.1002/ptr.4849 · Cited by 38 · see citing works

Effect of Wuzhi Tablet (Schisandra sphenanthera extract) on the Pharmacokinetics of Paclitaxel in Rats

Jin, J., Bi, H., Hu, J., et al. (2011) · Phytotherapy Research · doi:10.1002/ptr.3407 · Cited by 33 · see citing works

Synthesis and biological evaluation of novel bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potent P-glycoprotein inhibitors

Gu, X., Ren, Z., Tang, X., Peng, H., Zhao, Q. J., Lai, Y., Peng, S., & Zhang, Y. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.02.034 · Cited by 32 · see citing works

Enhancement of oral bioavailability of paclitaxel after oral administration of Schisandrol B in rats

Jin, J., Bi, H., Hu, J., et al. (2010) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.705 · Cited by 30 · see citing works

Effects of Dietary Factors on Drug Transport and Metabolism: The Impact on Dosage Guidelines in Transplant Patients

Nowack, R., Andrassy, J., Fischereder, M., & Unger, M. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.303 · Cited by 30 · see citing works

In vitro to in vivo evidence of the inhibitor characteristics of Schisandra lignans toward P-glycoprotein

Liang, Y., Zhou, Y., Zhang, J., et al. (2013) · Phytomedicine · doi:10.1016/j.phymed.2013.04.005 · Cited by 28 · see citing works

A Comprehensive Review of the Main Lignan Components of Schisandra chinensis (North Wu Wei Zi) and Schisandra sphenanthera (South Wu Wei Zi) and the Lignan-Induced Drug-Drug Interactions Based on the Inhibition of Cytochrome P450 and P-Glycoprotein Activities

Zhang, F., Zhai, J., Weng, N., Gao, J., Yin, J., & Chen, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.816036 · Cited by 30 · see citing works

Schisandra chinensis regulates drug metabolizing enzymes and drug transporters via activation of Nrf2-mediated signaling pathway

Zhou, S., He, J., Zhou, Z.-W., Yin, J., He, C.-Q., & Yu, Y. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s68501 · Cited by 29 · see citing works

Validation of an LC–MS/MS Method for Quantitative Analysis of the 5 Bioactive Components of Wuzhi Capsule in Human Plasma Samples

Wei, H., Miao, H., Yun, Y., et al. (2014) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000079 · Cited by 23 · see citing works

Identification of Key Structural Characteristics of Schisandra chinensis Lignans Involved in P-Glycoprotein Inhibition

Slanina, J., Páchniková, G., Čarnecká, M., et al. (2014) · Journal of Natural Products · doi:10.1021/np500521v · Cited by 22 · see citing works

Extraction and Separation of Active Ingredients in Schisandra chinensis (Turcz.) Baill and the Study of their Antifungal Effects

Yi, H., Chen, Y., Liu, J., Zhang, J., Guo, W. Y., Xiao, W., & Yao, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154731 · Cited by 21 · see citing works

Inhibiton of cytochrome P450 isoenzymes and P-gp activity by multiple extracts of Huang-Lian-Jie-Du decoction

Wang, Y., Jiang, Y., Wang, Y., et al. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.08.044 · Cited by 17 · see citing works

Effects of rhinacanthin-C on function and expression of drug efflux transporters in Caco-2 cells

Wongwanakul, R., Vardhanabhuti, N., Siripong, P., et al. (2013) · Fitoterapia · doi:10.1016/j.fitote.2013.05.019 · Cited by 17 · see citing works

Potential for pharmacokinetic interactions between Schisandra sphenanthera and bosutinib, but not imatinib: in vitro metabolism study combined with a physiologically‐based pharmacokinetic modelling approach

Adiwidjaja, J., Boddy, A., & McLachlan, A. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14303 · Cited by 18 · see citing works

Synthesis and evaluation of substituted dibenzo[c,e]azepine-5-ones as P-glycoprotein-mediated multidrug resistance reversal agents

Tang, X., Gu, X., Ren, Z., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.03.005 · Cited by 17 · see citing works

Quantitative analysis of olanzapine in rat brain microdialysates by HPLC–MS/MS coupled with column-switching technique

Zheng, Q., Wang, F., Huan-de, L., et al. (2012) · Journal of Chromatography B · doi:10.1016/j.jchromb.2012.07.024 · Cited by 15 · see citing works

Derivatives of schisandrin with increased inhibitory potential on prostaglandin E2 and leukotriene B4 formation in vitro

Blunder, M., Pferschy‐Wenzig, E., Fabian, W. M. F., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.10.031 · Cited by 15 · see citing works

Macelignan: A New Modulator of P-Glycoprotein in Multidrug-Resistant Cancer Cells

Im, Y. B., Ha, I., Kang, K. W., et al. (2009) · Nutrition and Cancer · doi:10.1080/01635580802666273 · Cited by 13 · see citing works

Pharmacokinetic Comparison of 20(R)‐ and 20(S)‐Ginsenoside Rh1 and 20(R)‐ and 20(S)‐Ginsenoside Rg3 in Rat Plasma following Oral Administration of Radix Ginseng Rubra and Sheng‐Mai‐San Extracts

Fan, X., Xu, Y., Zhu, D., et al. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/6451963 · Cited by 13 · see citing works

Cinnamophilin overcomes cancer multi-drug resistance via allosterically modulating human P-glycoprotein on both drug binding sites and ATPase binding sites

Teng, Y., Huang, B.-H., Huang, S.-Y., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112379 · Cited by 12 · see citing works

Multidrug Resistance in Cancer: A Tale of ABC Drug Transporters

Kapoor, K., Sim, H. M., & Ambudkar, S. V. (2013) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-1-4614-7070-0_1 · Cited by 11 · see citing works

Wuzhi capsule increased systemic exposure to methotrexate by inhibiting the expression of OAT1/3 and P-gp

Fu, R., Wang, X., Guo, C., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-1303 · Cited by 8 · see citing works

Assessment and modulation of phillyrin absorption by P-gp using Caco-2 cells and MDR1-MDCKII cells

Li, Y., Ye, L.-H., Jiang, X., & Peng, C. Y. (2011) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-011-0026-0 · Cited by 8 · see citing works

Effects of flavonoids derived from Taxus yunnanensis on p-glycoprotein and cytochrome P450 3A4

Li, J., Cai, D., Bi, H., et al. (2013) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2013.07.022 · Cited by 8 · see citing works

P-glycoprotein mediated interactions between Chinese materia medica and pharmaceutical drugs

Yang, X., Peng, Y., He, Y., Huang, X., Xu, A., Bi, X., & Xie, Y. (2021) · Digital Chinese Medicine · doi:10.1016/j.dcmed.2021.12.001 · Cited by 6 · see citing works

Effect of drug combination on tacrolimus target dose in renal transplant patients with different CYP3A5 genotypes

Zhang, S.-F., Tang, B., Wei, A., et al. (2022) · Xenobiotica · doi:10.1080/00498254.2022.2064252 · Cited by 6 · see citing works

Adaptogens - use, history and future

Marciniak, A., Nemeczek, S., Walczak, K., Walczak, P., MERKISZ, K., Grzybowski, J., Grzywna, N., JASKUŁA, K., & ORŁOWSKI, W. (2023) · Quality in Sport · doi:10.12775/qs.2023.09.01.002 · Cited by 3 · see citing works

Phytochemical Modulators of Human Drug Metabolism: Drug Interactions with Fruits, Vegetables, and Botanical Dietary Supplements

Gurley, B. J., Fifer, K. E., & Gardner, Z. (2012) · Encyclopedia of Drug Metabolism and Interactions · doi:10.1002/9780470921920.edm086 · Cited by 2 · see citing works

Pharmacokinetic Interaction of Plant Preparations with Chemical Drugs

Wen, Q., Chang-Xiao, L. I. U., Yang, J. U., & ZHANG, H.-Y. (2010) · Chinese Journal of Natural Medicines · doi:10.3724/sp.j.1009.2010.00137 · Cited by 1 · see citing works

A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes

Twentyman, P. R., Rhodes, T., & Rayner, S. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90187-2 · Cited by 129 · see citing works

Effect of the novel antipsychotic drug perospirone on P-glycoprotein function and expression in Caco-2 cells

Zhou, Y., Li, K., & Huan-de, L. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0487-5 · Cited by 13 · see citing works

Quercetin potentiates the effect of Adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target

Cianfriglia, M., Mancuso, S., Scambia, G., et al. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050173 · Cited by 23 · see citing works

Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures

Hirsch‐Ernst, K. I. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00457-7 · Cited by 30 · see citing works

Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.

Lee, J. S., Paull, K. D., Alvarez, M., Hose, C. D., Monks, A., Grever, M. R., Fojo, A. T., & Bates, S. E. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09793-7 · Cited by 336 · see citing works